These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28582561)

  • 21. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
    Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network.
    Bankamp B; Anderson R; Hao L; Lopareva E; Chen MH; Kim G; Beard RS; Mori Y; Otsuki N; Ryo A; Rota PA
    Vaccines (Basel); 2024 Jul; 12(8):. PubMed ID: 39203950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of measles and rubella integrated surveillance system in Apulia region, Italy, 3 years after its introduction.
    Turiac IA; Fortunato F; Cappelli MG; Morea A; Chironna M; Prato R; Martinelli D
    Epidemiol Infect; 2018 Apr; 146(5):594-599. PubMed ID: 29532766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global measles and rubella laboratory network support for elimination goals, 2010–2015.
    Wkly Epidemiol Rec; 2016 May; 91(18):240-6. PubMed ID: 27156255
    [No Abstract]   [Full Text] [Related]  

  • 25. [The running status of Chinese Measles Laboratory Network in 2008].
    Zhang Y; Xu ST; Jiang XH
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):104-7. PubMed ID: 20077651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
    Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase.
    Santibanez S; Hübschen JM; Ben Mamou MC; Muscat M; Brown KE; Myers R; Donoso Mantke O; Zeichhardt H; Brockmann D; Shulga SV; Muller CP; O'Connor PM; Mulders MN; Mankertz A
    Clin Microbiol Infect; 2017 Aug; 23(8):516-523. PubMed ID: 28712666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008.
    Cavallaro KF; Sandhu HS; Hyde TB; Johnson BW; Fischer M; Mayer LW; Clark TA; Pallansch MA; Yin Z; Zuo S; Hadler SC; Diorditsa S; Hasan AS; Bose AS; Dietz V;
    Vaccine; 2015 Feb; 33(9):1168-75. PubMed ID: 25597940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges of measles and rubella laboratory diagnostic in the era of elimination.
    Hübschen JM; Bork SM; Brown KE; Mankertz A; Santibanez S; Ben Mamou M; Mulders MN; Muller CP
    Clin Microbiol Infect; 2017 Aug; 23(8):511-515. PubMed ID: 28412379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory confirmation of rubella infection in suspected measles cases.
    Vaidya SR; Raut CG; Jadhav SM
    J Med Virol; 2016 Oct; 88(10):1685-9. PubMed ID: 27018071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Measles Laboratory Network in the region of the Americas.
    Venczel L; Rota J; Dietz V; Morris-Glasgow V; Siqueira M; Quirogz E; Rey G; de Quadros C
    J Infect Dis; 2003 May; 187 Suppl 1():S140-5. PubMed ID: 12721905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of global virologic surveillance for rubella viruses.
    Abernathy ES; Hübschen JM; Muller CP; Jin L; Brown D; Komase K; Mori Y; Xu W; Zhu Z; Siqueira MM; Shulga S; Tikhonova N; Pattamadilok S; Incomserb P; Smit SB; Akoua-Koffi C; Bwogi J; Lim WW; Woo GK; Triki H; Jee Y; Mulders MN; de Filippis AM; Ahmed H; Ramamurty N; Featherstone D; Icenogle JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S524-32. PubMed ID: 21666209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post Vaccine Rubella During a Measles Outbreak: Clinical Case.
    Graça L; Pereira S; Duro R; Sarmento A
    Acta Med Port; 2021 Feb; 34(2):139-142. PubMed ID: 31851892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):492-495. PubMed ID: 32091024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.
    Rachlin A; Hampton LM; Rota PA; Mulders MN; Papania M; Goodson JL; Krause LK; Hanson M; Osborn J; Kelly-Cirino C; Evans B; Sinha A; Warrener L; Featherstone D; Brown D
    Vaccines (Basel); 2024 Jul; 12(8):. PubMed ID: 39203949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
    J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.